NASOPHARYNGEAL CARCINOMA

This early-stage trial tested a new treatment for a type of throat cancer linked to the Epstein-Barr virus. Researchers took patients' own immune cells, engineered them to recognize and attack the virus-infected cancer cells, and also added a feature to boost their cancer-killing…

This study looked at 338 people with intermediate-risk nasopharyngeal cancer to see if modern radiation therapy alone is as good as radiation plus chemotherapy. Participants either got radiation alone or radiation with cisplatin chemo. The goal was to see if skipping chemo still …

This study tested whether adding the immunotherapy drug pembrolizumab after standard chemoradiation helps control advanced nasopharyngeal cancer. Fifty-three patients received up to 17 cycles (about 1 year) of pembrolizumab. The main goal was to see how many patients remained can…

This study tested a drug called KL-A167 in 153 adults with nasopharyngeal carcinoma that had come back or spread. The goal was to see if the drug could shrink tumors. Participants had already tried other treatments. The study measured how many people responded to the drug and how…

This study tested whether adding the immunotherapy drug nivolumab to standard chemoradiation helps patients with stage II-IVB nasopharyngeal cancer. Forty adults received the combination, and researchers measured how many completed all planned treatments and how well the cancer r…

This study tested a combination of two drugs, TQB2618 and penpulimab, in 47 people with advanced nasopharyngeal carcinoma that had returned or spread. Some participants had already tried standard treatments, while others were new to therapy. The goal was to see if the combo is sa…

This study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) followed by standard radiation and chemo in 60 people with advanced nasopharyngeal cancer, a type of throat cancer common in southern China. The goal was to see if this approac…

This study tested whether combining MRI scans with a special ultrasound (contrast-enhanced ultrasound) can better detect small cancer spread in neck lymph nodes of people with nasopharyngeal carcinoma. 348 patients with suspected small lymph node involvement were enrolled. The go…

This study looked at whether three blood proteins (pre-albumin, retinol binding protein, and transferrin) can help detect early malnutrition in people with advanced nasopharyngeal cancer undergoing chemoradiotherapy. Researchers measured these proteins and tracked weight changes …